Diabetic Under 70 (Diabetics Below 70)
A screening project of diabetics with a very high cardiovascular risk (e.g. diabetes plus coronary heart disease) who already receive cholesterol-lowering therapy. Lipid profile and rate of patients who are treated to target (which is <70mg/dl for such patients with very high risk) are screened. The doctors therapy decisions after the screening will be documented and 8-10 weeks later the lipid profile of each patient will be evaluated again. Our aim is to evaluate dosing habits, to evaluate how many patients are treated to their LDL-C target and to underline the importance of treating patients to their cholesterol targets.
Status: Active, not recruiting (N/A). Started on July 1st, 2007.
Enrollment: 1400 subjects
Study Type: Observational
Study Design:
- Prospective
Conditions:
Interventions:
- Drug: Any cholesterol-lowering drug
Eligibility
Inclusion Criteria:
- Diabetics with hyperlipidemia and atherosclerosis (coronary heart disease, carotid stenosis, PAVK, etc.) who already receive cholesterol-lowering therapy
Exclusion Criteria:
- Diabetics w/o CVD; diabetics who do not receive cholesterol-lowering therapy
- Gender
Both
- Mininum Age
18 Years
- Maximum Age
N/A
- Healthy Volunteers
No
Resources
Source: AstraZeneca
Authority: Not required for this study:
Locations
-
Research Site
Vienna
Austria
Officials
Michael Roden, MD (Study Chair, Chairs of the Austrian Diabetes Society)
Sponsors
AstraZeneca (Lead Sponsor)
References
None.
Links
None.
- Date Verified
- January 1st, 2009
- First Received
- January 21st, 2009
- Last Changed
- January 21st, 2009
Information obtained from ClinicalTrials.gov on January 22, 2009. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.